Cyclerion Therapeutics (CYCN) Earnings Date, Estimates & Call Transcripts → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free CYCN Stock Alerts $2.88 -0.27 (-8.57%) (As of 05/14/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCYCN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CYCN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. CYCN Earnings Date and InformationCyclerion Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 26th, 2024 based off prior year's report dates.Read More Get Cyclerion Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CYCN and its competitors with MarketBeat's FREE daily newsletter. Cyclerion Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/26/2024Estimated)------- 11/13/2023Q3 2023-($0.93)($0.93)($4.58)--7/28/2023Q2 2023-($1.83)($1.83)($1.83)--5/11/2023Q1 2023-($3.20)($3.20)($3.20)--3/22/2023Q4 2022-($3.20)($3.20)($0.16)-$0.61 million11/3/2022Q3 2022($7.00)($4.80)+$2.20($0.24)--8/9/2022Q2 2022($6.80)($6.20)+$0.60($0.31)$0.71 million$0.31 million Get the Latest News and Ratings for CYCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/4/2022Q1 2022($7.20)($6.00)+$1.20($0.30)$0.55 million$0.71 million2/24/2022Q4 2021($6.40)($4.80)+$1.60($0.24)$1.80 million$0.53 million11/9/2021Q3($7.00)($5.20)+$1.80($0.26)$3.00 million$0.35 million7/29/2021Q2 2021-($9.00)($9.00)($0.45)-$3.00 million Cyclerion Therapeutics Earnings - Frequently Asked Questions When is Cyclerion Therapeutics's earnings date? Cyclerion Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 26th, 2024 based off last year's report dates. Learn more on CYCN's earnings history. How much revenue does Cyclerion Therapeutics generate each year? Cyclerion Therapeutics (NASDAQ:CYCN) has a recorded annual revenue of $1.62 million. How much profit does Cyclerion Therapeutics generate each year? Cyclerion Therapeutics (NASDAQ:CYCN) has a recorded net income of -$5.26 million. CYCN has generated $0.00 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Vaccinex Earnings Results eFFECTOR Therapeutics Earnings Results Hepion Pharmaceuticals Earnings Results Virios Therapeutics Earnings Results Pasithea Therapeutics Earnings Results Cadrenal Therapeutics Earnings Results Trevena Earnings Results Can-Fite BioPharma Earnings Results NuCana Earnings Results Biofrontera Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:CYCN) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBill Clinton Backing Biden Replacement???The Freeport SocietyHow to Play the AI and Crypto Markets in One SwingWeiss RatingsAmazon's betting big on this unknown AI companyManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.